Basel Medical Group Ltd (BMGL)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Revenue$11.3M$10.1M
Net income−$10.6M$2.1M
Basic EPSper diluted share-SGD 0.64SGD 0.13
Diluted EPSper diluted share-SGD 0.57SGD 0.13

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.